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Summary 
Equilibrium binding studies with recombinant human chemoattractant cytokines Rantes  and 
monocyte chemoattractant protein 1 (MCP-1) on monocytic THP-1 cells have allowed the functional 
identification of two distinct receptors for C-C chemokines. One is a novel oligospecific receptor 
with high affinity for Rantes (50% maximal inhibitory concentration [ICs0], 0.68 nM) and low 
affinity (ICs0, 35 nM) for MCP-1, while the other is the previously described specific receptor 
for MCP-1 (ICs0, 0.5 nM). Receptor affinity for Rantes is enhanced on preparation  of isolated 
membranes with a 12-fold decrease in receptor Kd. The basis of this enhancement is not un- 
derstood.  The Rantes receptor appears to be G protein linked, as binding activity is abolished 
by guanosine 5'-O-(3-thiotriphosphate)  (ICs0, 7.3  nM).  In contrast  to  the consequences  of 
MCP-1 binding, we were unable  to demonstrate ligand-dependent calcium fluxes on binding 
of Rantes to human monocytes or THP-1 cells. The binding of Rantes and MCP-1 to mononuclear 
cells from dog, rabbit,  and rat were tested. While high affinity binding could be demonstrated 
in dog and rabbit,  differences in ligand-induced Ca  2+ fluxes could be shown between species. 
This  suggests  that receptor-ligand  interactions  and receptor  coupling is best  examined with 
autologous receptors  and cytokine. 
U 
nderstanding of the molecular basis of the focal recruit- 
ment of monocytes and lymphocytes to sites of chronic 
inflammation remains incomplete. Identification of leukocyte- 
endothelial adhesion and homing molecules has provided some 
molecular insights  into  the inflammatory recruitment of 
monocytes (1), the recirculation of naive lymphocytes through 
high endothelium, and the induced migration of activated 
and memory T cells through unspecialized  postcapiUary  venule 
(2). The recent convergence of studies on chemotactic cyto- 
kines, gene expression in activated leukocytes, and leukocyte 
adhesion molecules provide tools to dissect these interrela- 
tionships  governing inflammatory leukocyte recruitment. 
Rantes and monocyte chemoattractant protein 1 (MCP-1) 
are members of the intercrine (3) or chemokine (4) family 
ofproinflammatory basic chemoattractant polypeptides. These 
cytokines, defined initially as genes expressed in activated leu- 
kocytes or as small platelet-derived growth factor (PDGF)- 
inducible genes, are structural members of the C-C branch 
of the chemokine family (5), based on the adjacent position 
of the first two of a highly conserved four-cysteine motif (5). 
Both MCP-1 and Rantes are cell specific in their activation 
or chemoattractant activities. MCP-1 activity is restricted to 
monocytes and basophils (6-8), while Rantes has been reported 
to be chemotactic for both monocytes, eosinophils (9) and 
the UCHLl-positive (low molecular weight CD45 isoform) 
memory subset of T cells (10). MCP-1 is expressed at sites 
of monocyte infiltration  into tissues, such as early athero- 
sclerotic lesions, or after vascular injury (11-13), and has been 
postulated to contribute to monocyte migration to such sites. 
The biological  and pathological  contributions of these 
chemokine family members to inflammation and tissue re- 
pair remain to be elucidated experimentally, although a va- 
riety of proinflammatory effects have apparently been demon- 
strated by the injection of these cytokines in vivo (14). These 
include inflammatory recruitment of either neutrophils or 
mononuclear cells, depending upon the specific cytokine. It 
has been suggested, without causal evidence, that these mol- 
ecules play an important role in inflammatory recruitment 
leading to cell activation and directional migration of specific 
leukocyte subsets, and contribute to activation of integrin- 
mediated adhesive  events necessary for transendothelial migra- 
tion (2). 
Analysis of chemokine receptors is helpful in correlating 
levels ofcytokine expression with potential effects and is also 
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of the in vivo contribution of cytokines to inflammatory and  xJ 
t- 
immune pathology. To help clarify the relationship between  ",  o 
chemokine presence and cell migration,  we have character-  m 
ized the human,  rabbit,  and dog receptors for Rantes  and  E  3000 
MCP-1, and demonstrate complexities of receptor-ligand rela-  u~ 
tionships and receptor coupling among this family of mol- 
ecules.  ~  - 
~0  2000 
Materials  and Methods 
Cells and Membrane Preparation.  THP-1 cells were cultured in  - 
IMDM with 10% FCS (Gibco Laboratories,  Grand Island,  NY). 
Plasma membranes were prepared by nitrogen bomb cavitation and 
differential centrifugation as described (15). Membrane preparations 
were resuspended at 3.3-3.5 mg/ml in 10 mM Hepes, pH 7.50, 
with PMSF, aprotinin, chymostatin,  and hupeptin (all at 10/~g/ml).  b  2000 
MCP-1 and Rantes.  Recombinant ligands were purchased from 
Peprotech (Princeton, NJ) and iodinated with chloramine-T ac- 
"O 
cording to Rollins and Springer (16). Specific activities  were 45  c 
and 46/~Ci//~g  for MCP-1 and Rantes, respectively,  m  ~  15oo 
Binding Assays.  Binding of 1-2  x  104 cpm of lzsI ligands  in 
the presence of varying concentrations of unlabeled ligand to cells  E  o. 
or membranes at room temperature was assayed in 50 mM Hepes,  o 
1 mM CaC12, 5 mM MgCI2,  0.5%  BSA, pH  7.2.  Activity re-  ~  lo00 
tained on polyethyleneimine-treated Whatman GFC filters  after  =  o 
washing in binding buffer with 0.5 M  NaCI was  counted in a  a:  I 
gamma  counter  (LKB Instruments,  Inc.,  Gaithersburg,  MD).  ~  500 
Binding constants were calculated and Scatchard analysis was per-  - 
formed on competition binding assays using the LIGAND program. 
Inhibition of  Binding by Guanosine  5'-O.(3-Thiotriphosphate)  (GTI~S). 
The binding of a constant concentration of xzsI ligand to THP-1 
plasma membranes preincubated for 30 rain at room temperature 
in varying concentrations of GTP'yS or ATP (Boehringer-Ingelheim) 
in binding buffer was  assayed as above. 
Ligand-induced Ca  2+ Fluxes.  Human or dog PBMC were pre- 
pared by density centrifugation on 1.077  g/m1 Ficoll-Hypaque. 
Rabbit cells were prepared on 1.084 g/ml Percoll. These cells along 
with various monocytic cell lines (THP-1, U937, or Monomac6) 
were incubated with 1.25/~g/ml Indo-1 in R.PMI  1640,  10 mM 
Hepes, 5% FCS for 60 rain at 37~  Loaded cells were washed 
by centrifugation and warmed to 37~  before varying concentra- 
tions of ligand were added.  Calcium analyses were performed on  800 
a FACS  |  analyzer (Becton Dickinson & Co., Mountain View, CA) 
with  an  excitation  wavelength  of 365  nm  and  dual  emission 
wavelengths of 405 and 488 nm. 
Results 
Rantes Binding to THP-1  Cells and Membranes.  Compe- 
tition binding studies on intact THP-1 cells identified a single 
high  affinity receptor with  an  ICs0 of 0.69 nM  (Ka, 0.39 
nM)  (Fig.  1 a) and  '~5,100 binding  sites/cell on Scatchard 
analysis. Preparation of isolated membranes from THP-1 cells 
resulted in the retention of a single high affinity binding site 
with an ICs0 of 0.05 nM. Scatchard analysis revealed that the 
Kd of the receptor had decreased to 13 pM (Fig.  1 b).  Nei- 
ther IL-8 nor CSa competed for Rantes binding. The binding 
properties of the Rantes receptor are summarized in Table 1. 
GPTTS Sensitivity of Rantes Binding.  Direct evidence of 
the GTP dependence and thus the G protein coupling of the 
Rantes receptor was provided by the GTP~/S sensitivity of 
iC50  0 6~ 
I  I  I  I  I  I  ,  I 
10000-12  10-11  10-~0  lO-g  lO-a  10-7  10  -s  10-5 
Molar  concentration  Ranfes 
~ 
,o,. O.O,n,,  \ 
KD O.04nM  ~o 
~'O~O  0  .A 4, 
I  I  I  I  I  I  I  I 
10-14  10-13  10-12  10-11  10-10  10  -9  10  -8  10  -7  10-6 
Molar  Concentration  Rantes 
Figure  1.  Equilibrium binding cold displacement  curve of one of three 
essentially similar experiments of 12SI-Rantes binding to THP-1 cells (a) 
or isolated THP-1 membranes (b) showing the increase  in receptor affinity 
upon cell disruption. The points represent the means of triplicate mea- 
surements with a superimposed  four-parameter  fit. The Scatchard  plot for 
the membrane preparation (inset) shows a single high affanity  receptor for 
12SI-Rantes with a Kd of 13 pM compared with 0.19 nM for THP-1 cells. 
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Figure 2.  GTPTS  inhibits the binding of Rantes to its high affinity 
receptor with an IC50 of 7.6 nM. Membranes preincubated with varying 
concentrations of GTPTS were then incubated in a constant amount of 
tzSI-Rantes. Points represent the means of triplicate measurements with 
a superimposed four-parameter fit. Essentially  similar data were obtained 
in each of two separate experiments. Adenine nucleotides were inactive. 
852  Binding  Studies of Rantes and Monocyte Chemoattractant Protein 1 Table  1.  Functional  Characteristics Cells Smface Receptors  for Rantes and MCP-1 
Kd 
Keceptor  Ligand  Cells  Membranes 
B~  GTP?S 
(sites/cell)  (ICso) 
RANTES  RANTES  0.96  _+  0.29 
(n  =  4) 
RANTES  MCP-1  105  +  29 
RANTES  IL-8 or C5a  No binding 
MCP-1  MCP-1  0.51  _+  0.36 
(n  =  4) 
MCP-1  RANTES  No binding 
MCP1  IL-8 or CSa  No binding 
nM 
0.02  _+  0.015  5,070  _+  108  7.3  nM 
(n  =  3) 
ND  3,010  ND 
No binding  ND  ND 
0.33  +  0.16  3,923  +_  1,285  32  nM 
(n  =  3) 
No binding  ND  ND 
No binding  ND  ND 
Rantes binding to isolated THP-1 membranes. Fig. 2 shows 
that GTP~/S addition to membranes led to a concentration- 
dependent inhibition of Rantes binding with an ICs0 of 7.6 
nM, an inhibition comparable to the GTP sensitivity of other 
high  a~nity  G-linked receptors. 
The High Affinity Rantes Receptor Has a Low Affinity for 
MCP-1 and Is Distinct from the High Affinity MCP-1 Receptor. 
Crosscompetition  experiments  using  mI-Rantes  and unla- 
beled MCP-1 or Rantes on THP-1 cells showed that MCP-1 
competed for the binding of iodinated Rantes with an ICs0 
of 35 nM (Fig. 3 a). This ICs0 was between 35- and 50-fold 
greater than the ICs0 for unlabeled Rantes (Fig.  1 a). In con- 
trast,  competition  experiments  on  THP-1  cells using  t2sI- 
MCP-1 and unlabeled MCP-1 identified a high affinity MCP-1 
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Figure  3.  (a) Equih'brinm binding cold displacement by MCP-1 of ml- 
Rantes binding to THP-1 cells demonstrating that MCP-1 binds with low 
affnity to the high affnity Rentes receptor. The points represent the means 
of triplicate measurements with a superimposed four-parameter fit. Essen- 
tially similar data were obtained in each of three separate experiments. 
(b) The binding of tZSl-MCP-1 to THP-1 cells is high affinity and dis- 
tinct from the displacement of t251-Rantes by cold MCP-1. The points 
represent the means of triplicate measurements with a superimposed four- 
parameter fit. Essentially similar data were obtained in each of three sepa- 
rate experiments. An ICs0 of 0.5 nM for unlabeled MCP-1 competition 
for mI-MCP-1 binding was obtained compared with the ICs0 of 35 nM 
for unlabeled MCP-1 competition for mI-Rantes.  Scatchard plot (inset) 
shows that THlXl cells have a single high affnity receptor for mI-MCP-1 
with  a Kd of 0.44  riM. (c) GTP~'S inhibits  the  specific high  affnity 
binding of MCP-1 to isolated THP-1 cell membranes. Essentially similar 
data were obtained in each of two separate experiments. Adenine nucleo- 
tides were inactive. 
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sites/cell (Fig. 3 b) when competed with MCP-1, while Rantes, 
Ib8, and C5a failed entirely to displace iodinated MCP-1 from 
its binding site. Furthermore,  the inhibitory effect of GTP~S 
on 12SI-MCP-1 binding to isolated membranes shows an ICs0 
of 32 nM,  and  is fourfold less  sensitive to inhibition  than  a  1.1  - 
the binding  of 12SI-Rantes (Fig.  3 c).  The  Rantes  receptor 
thus appears oligospecific, binding Rantes with high affinity  o 
and MCP-1 with low affinity,  while the high affinity MCP-1 
receptor is distinct and monospecific and appears not to share  a~ 
any binding activity for Rantes.  The comparison of the binding  ta 
properties of the two receptors are summarized in Table  1.  z 
The Different  Species  Distribution of  Human MCP-I and Rantes  r  (/3 
Binding.  Human  MCP-1  differs  significantly from rabbit,  ta 
tic 
mouse,  and  rat  MCP-1  in  the  absence of 25-48  COOH-  o  D 
terminal amino acids.  Despite this,  t2sI recombinant human  - 
MCP-1  bound  to human,  rabbit  (Ka,  0.04  nM),  dog,  and 
pig mononuclear cells (Fig. 4). However, there was no demon- 
strable binding of human MCP-1 to rat cells, in spite of the  -6 0 
reported in vivo activity of the natural human MCP-1 in rat 
(14). A specific binding signal on human, rat, dog, and rabbit 
cells was demonstrated  with  recombinant  Rantes  (Fig.  4).  b 
High A.~nity Rantes Binding Is Not Necessarily Coupled to 
a Ligand-induced Ca  2+ Flux.  The demonstration  of either  o 
Rantes or MCP-1 binding  activity does not always lead to  ~- 
the activation  of a Ca  2+  flux.  Analysis of intracellular  ca1-  a:  .9 
cium transients  upon binding of 1-100 nM MCP-1 led to a  ,.,  o  concentration-dependent  transient Ca  ~+ flux in both THP-1  z 
cells  (Fig.  5 a)  and human  monocytes, whereas binding  of  tao  .8 
Rantes failed to elicit a Ca  2  § flux in either peripheral blood  tat~ 
monocytes or THP-1 cells. Neither human Rantes nor human  ~  .7 
MCP-1 binding were able to induce a Ca  2+  flux (Fig.  5 b)  3  u_ 
in rabbit cells, despite high affinity binding. In contrast, both  .6 
Rantes and MCP-1 binding  activated a transient  Ca  2  + flux 
in dog monocytes (Fig.  5 c), although  the concentration  of  .5 
0  Rantes necessary to induce a significant  flux in dog mono- 
Figure 4.  Summary of the binding data obtained using human MCP-1 
and Rantes  on mononuclear cells from various animal species. The bars 
represent  the means  of triplicate  measurements  after subtraction  of the 
nonspecific binding (not competed by 100-fold  ~cess of unhbeled cytokine). 
Essentially similar data were obtained in each of three separate experiments. 
*Binding of human Rantes to pig mononuclear cells was not determined. 
cytes was  100 nM in comparison  with  10 nM for MCP-1. 
The  transient  Ca  2+  flux does not appear to be an essential 
component of the chemotactic response since Rantes induced 
human monocyte chemotaxis in chamber assays (not shown). 
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Figure 5.  (a) MCP-1 dose-dependent ligand induced calcium flux mea- 
sured by changes in Indo-1 fluorescence in THP-1 cells. No flux was seen 
with 100 nM Rantes.  (b) Neither MCP-1 nor Rantes  induced a calcium 
flux in Indo-l-loaded rabbit monocytes. (c) Dog monocytes undergo a ligand- 
induced  calcium  flux in response to both Rantes  and  MCP-1. 
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These data provide the first published evidence for the pres- 
ence of a shared receptor on THP-1 cells with high affinity 
for Rantes (Ka, 0.39 nM) and low affinity for MCP-1 (Ka, 
35 riM). In addition these cells have a specific high affinity 
receptor (Ka, 0.19 riM) for MCP-1 alone, that in our hands 
has ,'ol0-fold higher affinity than that previously observed 
(17, 18). These high affinity receptors are likely regulated by 
G proteins as ligand binding is abolished by preincubation 
of membranes with GTP3~S with a nanomolar ICs0. Since 
the Rantes receptor shows oligospecificity in its binding of 
ligands, and as both Rantes and MCP-1 can be produced in 
nanomolar quantities at sites of  chronic inflammation, it seems 
that some redundancy and biological complexity could be 
expected. Despite this, the Rantes receptor functionally should 
bind Rantes rather than MCP-1 under physiological condi- 
tions, because of its almost 100-fold greater affinity for Rantes 
than for MCP-1. 
Scatchard analysis of the Rantes binding site shows a single 
high affinity site on intact cells.  In addition,  these are the 
first data  showing the preservation  of a  C-C  chemokine 
receptor  on  isolated  membranes.  Equilibrium  binding  of 
Rantes to isolated THP-1 cell membranes identified a single 
high affinity site on such membranes, but the binding affinity 
had been increased. The cause of the change in affinity upon 
cell disruption remains uncertain but may relate to altera- 
tions of G protein coupling, as receptor affinity is tightly regu- 
lated by G proteins and the majority of binding is lost upon 
GTPTS  preincubation.  Although  MCP-1  binding  can be 
demonstrated on isolated THP-1 membranes, no similar in- 
crease in affinity is seen in such membrane preparations (data 
not shown). Increases in affinity upon disruption of cells have 
been documented for the CSa receptor (15). 
Binding ofligand to the Rantes receptor leads to chemotaxis 
of primary human monocytes in the absence of a measurable 
intracellular calcium flux. Binding of up to 100 nM Rantes 
to either human monocytes or THP-1 cells caused no cal- 
cium flux, although dog monocytes did show a Rantes-elicited 
calcium flux.  This confirms the notion that a measurable 
generalized cytosolic calcium flux is not an essential prereq- 
uisite for chemotaxis. This does not, however, exclude the 
possibility that localized, strategic calcium fluxes below the 
resolution of the FACS  |  technique play a role in the trans- 
duction events necessary for chemotaxis. It is interesting to 
note that two highly related cytokine ligands, both acting 
upon G-linked receptors that should also exhibit significant 
homology,  are so  distinct  in  their postreceptor signaling 
pathways,  namely MCP-1  being coupled to  a  Ca  2+  flux, 
whereas Rantes dicited no such response. Assessing the bio- 
logical relevance of such different pathways may shed light 
on the mechanisms by which monocytes discern their migra- 
tory path using the complex mixtures and potential redun- 
dancies ofchemoattractant cytokines being generated at inflam- 
matory sites. 
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